Peter Kies - Net Worth and Insider Trading

Peter Kies Net Worth

The estimated net worth of Peter Kies is at least $156,145 dollars as of 2024-03-29. Peter Kies is the CFO of Inovio Pharmaceuticals Inc and owns about 11,274 shares of Inovio Pharmaceuticals Inc (INO) stock worth over $156,145. Details can be seen in Peter Kies's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Kies has not made any transactions after 2021-06-09 and currently still holds the listed stock(s).

Transaction Summary of Peter Kies

To

Peter Kies Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Kies owns 1 companies in total, including Inovio Pharmaceuticals Inc () .

Click here to see the complete history of Peter Kies’s form 4 insider trades.

Insider Ownership Summary of Peter Kies

Ticker Comapny Transaction Date Type of Owner
Inovio Pharmaceuticals Inc 2021-06-09 CFO

Peter Kies Latest Holdings Summary

Peter Kies currently owns a total of 1 stock. Peter Kies owns 11,274 shares of Inovio Pharmaceuticals Inc (INO) as of June 9, 2021, with a value of $156,145.

Latest Holdings of Peter Kies

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INO Inovio Pharmaceuticals Inc 2021-06-09 11,274 13.85 156,145

Holding Weightings of Peter Kies


Peter Kies Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Kies has made a total of 6 transactions in Inovio Pharmaceuticals Inc (INO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Inovio Pharmaceuticals Inc is the sale of 2,812 shares on June 9, 2021, which brought Peter Kies around $337,838.

Insider Trading History of Peter Kies

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Kies Trading Performance

GuruFocus tracks the stock performance after each of Peter Kies's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Kies is 14.53%. GuruFocus also compares Peter Kies's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Kies within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Kies's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Kies

Average Relative Return

14.28%

Average relative return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 16.28 14.53 15.61 14.28 68.26 31.14
Relative Return to S&P 500(%) 10.39 6.92 6.57 -0.56 53.99 17.48

Peter Kies Ownership Network

Ownership Network List of Peter Kies

No Data

Ownership Network Relation of Peter Kies


Peter Kies Owned Company Details

What does Inovio Pharmaceuticals Inc do?

Who are the key executives at Inovio Pharmaceuticals Inc?

Peter Kies is the CFO of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , Chief Scientific Officer Laurent Humeau , and Chief Operating Officer Jacqueline Elizabeth Shea .

Inovio Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Peter Kies made no insider transaction in Inovio Pharmaceuticals Inc (). Other recent insider transactions involving Inovio Pharmaceuticals Inc () include a net sale of 17,501 shares made by David B. Weiner , and a net sale of 5,700 shares made by Lota S. Zoth .

In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,933 shares of Inovio Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,933 shares.

Inovio Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inovio Pharmaceuticals Inc Insider Transactions

No Available Data

Peter Kies Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Kies. Currently GuruFocus does not have mailing address information for Peter Kies.

Discussions on Peter Kies

No discussions yet.